Faster, more inclusive trials, together
Inato (inato.com) earns a Brand Analyzer score of 81 out of 100, placing it in the Strong Brand tier among Healthcare brands, SaaS brands, Technology brands. Among 3492 Healthcare brands analyzed, Inato ranks in the 83rd percentile (category average 72, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 100/100, AI Discoverability 77/100, Brand Authority 23/100.
Inato is a technology company operating an AI-powered platform that connects pharmaceutical sponsors, clinical research sites, and patients to improve the efficiency and inclusivity of clinical trials. The platform matches qualified research sites to trials based on their actual capabilities and patient access, aiming to expand global access to clinical research. Inato serves the healthcare and clinical research industry, positioning itself as a single intelligent platform bridging sponsors and sites worldwide.
| Brand Name | Inato |
|---|---|
| Domain | inato.com |
| Industry | Healthcare, SaaS |
| Main Competitors | Medable (86/100), Deep 6 AI (55/100), Antidote (81/100), TriNetX (84/100), Reify Health (66/100), Science 37 |
Moz Domain Authority 35/100 vs category average 35 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Inato unites sponsors, research sites, and patients through one AI-powered platform, expanding access, increasing efficiency, and bringing life-changing treatments to more communit…" (Meta description: 25 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt mentions GPTBot, ChatGPT-User, ClaudeBot, Google-Extended, PerplexityBot - all allowed - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, Webflow.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Inato scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Inato has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (63/100) and its weakest is trust (15/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 35/100 and thin schema.org structured data. In a live check, Claude could already identify Inato from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Inato?", Claude could identify the brand as of August 2026. Inato is a clinical trial marketplace that connects pharmaceutical companies and CROs with a global network of hospitals and community clinics to speed up patient recruitment for clinical trials. It aims to democratize access to clinical research by bringing trials to more divers Best known for Its online marketplace model that matches clinical trial sponsors with hospital and clinic sites to improve patient recruitment speed and diversity.
When asked "Best brands similar to Inato?", Claude would recommend Inato as of August 2026. It's a recognized and somewhat unique player in the clinical trial site matching space, so it would come up if discussing solutions for patient recruitment or trial site diversification.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Inato's main competitors include Medable, Deep 6 AI (55/100), Antidote (81/100), TriNetX, Reify Health. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Inato and Antidote are competitors in Healthcare. Brand Analyzer scores Inato at 81/100 and Antidote at 81/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Inato include Medable, Deep 6 AI (55/100), Antidote (81/100), TriNetX, Reify Health. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Inato has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 15, trust 15, recommendation 63). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Inato official site
Inato scores 63/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Inato official site
Inato offers an AI-powered platform that connects pharmaceutical sponsors, clinical research sites, and patients to facilitate the planning and execution of clinical trials. The platform's core service is matching research sites to trials based on their real capabilities and patient access, aiming to increase efficiency and inclusivity in clinical research.
Sources: Inato official site
Inato is a healthcare technology company that operates an AI-powered platform designed to unite pharmaceutical sponsors, clinical research sites, and patients in the clinical trial process. It falls within the Healthcare, SaaS, and Technology categories, and positions itself as a single intelligent platform connecting the parties involved in running clinical trials globally.
Sources: Inato official site
Inato uses artificial intelligence to match clinical trial sponsors with qualified research sites based on the sites' real capabilities and access to patients. This matching process is intended to increase the efficiency, inclusivity, and speed of clinical trials, while expanding access to trial participation for more communities around the world.
Sources: Inato official site
Inato can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Inato official site
Inato's platform is used by pharmaceutical sponsors and clinical research sites that seek to run more efficient, inclusive, and globally accessible clinical trials.
Sources: Inato official site
Inato is known for being a platform that connects clinical trial sponsors and research sites using AI-based matching, with a focus on improving access and inclusivity in clinical research rather than relying on traditional, less efficient site-selection methods.
Sources: Inato official site
Ranked closest to Inato: Iceotope (81/100), Host Defense (81/100), Institute for Integrative Nutrition (81/100), iRhythm (81/100).
A step up - brands to learn from: theSkimm (91/100), Oura (91/100).
Category leader: Elsevier (96/100).